JESSICA BOYD: Open Payments
NPI 1801301627 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,551 in 148 payments from 25 companies in 2025. Trend: 2023 $3,983 · 2024 $3,601 · 2025 $3,551
Food & beverage: $3,351Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $420 |
| Amgen Inc. | 23 | $407 |
| Mallinckrodt Hospital Products Inc. | 8 | $362 |
| PFIZER INC. | 17 | $339 |
| Janssen Biotech, Inc. | 5 | $308 |
| ANI Pharmaceuticals, Inc. | 10 | $250 |
| UCB, Inc. | 13 | $249 |
| GlaxoSmithKline, LLC. | 8 | $184 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $127 |
Products named: ACTHAR, TREMFYA, RINVOQ, PURIFIED CORTROPHIN GEL, Bimzelx, XELJANZ, BENLYSTA, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across GA — which companies pay providers there.
